107 coding-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "U.S" "U.S" "U.S" "U.S" research jobs at Northeastern University
Sort by
Refine Your Search
-
® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is also approved for the treatment
-
BioNTech BioNTech is a Germany-based biotechnology company with U.S. offices in Cambridge, MA, Berkeley Heights, NJ and Gaithersburg, MD, that focuses on developing cancer therapeutics, including
-
biochemistry, genetics, microbiology, and cell biological approaches. For more information check the Saavedra lab website: https://www.saavedralab.com The successful candidate for this role will join a
-
U.S. PhD degree candidates Additional Information Applicants should submit the following application materials by the priority deadline of October 31, 2025: 1. Curriculum vitae (CV), uploaded 2
-
, biomedicine, and other areas of societal importance. Coding and/or machine learning experiences are highly valued. Specific projects may involve developing multiscale simulation methods for quantum mechanical
-
support. In addition, Ironwood has been a pioneer in the development of LINZESS (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C
-
strategy Support the development and lifecycle maintenance submissions for commercial programs Assist in the preparation of U.S. and/or international regulatory submissions as assigned Qualifications Doctor
-
-functionally across U.S. and global teams, key activities include mapping the clinical landscape, fostering scientific engagement with key opinion leaders (KOLs) and other stakeholders, and supporting
-
functional supervision over graduate and undergraduate students. The appointment generally does not extend beyond two years. To learn more about the work in the group, checkout out the group website. https
-
support. In addition, Ironwood has been a pioneer in the development of LINZESS (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C